| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |